Pentalysine beta-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy (vol 5, pg 890, 2010)

Graduate University of Chinese Academy of Sciences, 19 Yuquan Road, Shijingshan District, Beijing 100049, China.
ChemMedChem (Impact Factor: 3.05). 06/2010; 5(6):890-8. DOI: 10.1002/cmdc.201000042
Source: PubMed

ABSTRACT Unsymmetrical phthalocyanine derivatives have been widely studied as photosensitizers for photodynamic therapy (PDT), targeting various tumor types. However, the preparation of unsymmetrical phthalocyanines is always a challenge due to the presence of many possible structural isomers. Herein we report a new unsymmetrical zinc phthalocyanine, pentalysine beta-carbonylphthalocyanine zinc (ZnPc-(Lys)(5)), that was prepared in large quantity and high purity. This is a water-soluble cationic photosensitizer and maintains a high quantum yield of singlet oxygen generation similar to that of unsubstituted zinc phthalocyanine (ZnPc). Compared with anionic ZnPc counterparts, ZnPc-(Lys)(5) shows a higher level cellular uptake and 20-fold higher phototoxicity toward tumor cells. Pharmacokinetics and PDT studies of ZnPc-(Lys)(5) in S180 tumor-bearing mice showed a high ratio of tumor versus skin retention and significant tumor inhibition. This new molecular framework will allow synthetic diversity in the number of lysine residues incorporated and will facilitate future QSAR studies.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Photodynamic therapy (PDT) has attracted strong interest in the treatment of cancer due to the increased incidence of multidrug resistance and systemic toxicity in conventional chemotherapy. Phthalocyanine (Pc) is one of main classes of photosensitizers for PDT with optimal photophysical and photochemical properties. A higher specificity can ideally be achieved when Pcs are targeted towards tumor specific receptors, which may also facilitate specific drug delivery. Herein, we develop a simple and unique strategy to prepare a hydrophilic tumor-targeting photosensitizer ATF-ZnPc by covalently coupling zinc phthalocyanine (ZnPc) to the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (uPA), a fragment responsible for uPA receptor (uPAR, a biomarker over-expressed in cancer cells), through the carboxyl groups of ATF. We demonstrate the high efficacy of such tumor-targeting PDT agent for the inhibition of tumor growth both in vitro and in vivo. Our in vivo optical imaging results using H22 tumor-bearing mice show clearly the selective accumulation of ATF-ZnPc in tumor region, thereby revealing the great potential of ATF-ZnPc for clinical applications such as cancer detection and guidance of tumor resection in addition to photodynamic treatment.
    Acta Biomaterialia 06/2014; 10(10):4257-4268. DOI:10.1016/j.actbio.2014.06.026 · 5.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Herein we present the synthesis and full characterization of the water-soluble [1,4-bis(α,β-galactopyranos-6-yl)phthalocyaninato]zinc(II) (8). For a cross-condensation with phthalonitrile in presence of zinc bromide, bisglycosylated phthalonitrile (5) has been synthesized by nucleophilic displacement of triflyl groups or fluorine atoms by acetonide protected galactose in the appropriated phthalonitriles 1 and 2. Furthermore we prepared 3,6-bis(1,2:3,4-di-O-isopropylidene-α-D-galactopyranos-6-yl)phthalonitrile (5) starting from 2,3-dicyanohydroquinone and 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose using a Mitsunobu protocol. UV-vis spectra of 8 were measured in DMSO, water and PBS-buffer at different concentrations.
    Journal of Porphyrins and Phthalocyanines 08/2013; 17(08n09). DOI:10.1142/S1088424613500387 · 1.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Bacterial infection is a common clinical problem. The emergence of antibiotic resistant bacteria posts a severe challenge to medical practice worldwide. Photodynamic antimicrobial chemotherapy (PACT) uses laser light at specific wavelength to activate oxygen molecule in the human tissue into reactive oxygen species as antimicrobial agent. This activation of oxygen by laser light is mediated through a photosensitizer. Two key properties for potent photosensitizer are its absorbance of light in the infrared region (630–700 nm), which promotes tissue penetration depth, and the selective accumulation on bacteria instead of human tissue. We herein report a zinc phthalocyanine derivative, pentalysine β-carbonylphthalocyanine zinc (ZnPc-(Lys) 5) and its antimicrobial effects in vitro and in an animal infection model. This photosensitizer has strong capability to kill bacteria at 670 nm. Chemically, it is a water-soluble and cationic photosensitizer carrying positive charge under physiological pH, and can specifically target to bacteria which usually bears negative charges on its surface. Compared with anionic ZnPc counterparts, ZnPc-(Lys) 5 shows a higher phototoxicity toward bacteria. PACT studies of ZnPc-(Lys) 5 in experimental infection animal model showed a significant bacteria inhibition compared to controls, and high selectivity of ZnPc-(Lys) 5 toward bacteria. These findings suggest ZnPc-(Lys) 5 is a promising antimicrobial photosensitizer for the treatment of infectious diseases. & 2013 Elsevier B.V. All rights reserved.
    Journal of Luminescence 08/2014; 152:103-107. DOI:10.1016/j.jlumin.2013.10.067 · 2.37 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014